605077 Zhejiang Huakang Pharmaceutical
- 13.09
- +0.07+0.54%
Zhejiang Huakang Pharmaceutical News
Check opinions of the board of supervisors of Huakang Co., Ltd. on the adjustment of the company's 2023 restricted stock incentive plan and the reservation of related matters for granting.
Reserved list of incentive recipients for Huakang Holdings' 2023 restricted stock incentive plan
Legal Opinion of Guohao Law Firm (Hangzhou) on the Adjustment and Reserved Grant of Restricted Stock Incentive Plan of Zhejiang Huakang Pharmaceutical Co., Ltd. in 2023
Announcement from Huakang Corporation regarding the grant of restricted stocks to the participants of the company's 2023 restricted stock incentive plan.
华康股份关于调整 2023 年限制性股票激励计划相关事项的公告
Huakang Co., Ltd. 2023 Equity Distribution Implementation Notice
Announcement on the Company's 2023 Profit Distribution and Provident Fund Share Capital Transfer Plan
Announcement of Huakang Co., Ltd. on the listing and circulation of some restricted shares in the initial public offering
Announcement of Huakang Co., Ltd. on the pledge of part of the shares of the controlling shareholder
Announcement of Huakang Co., Ltd. on the results of the first restricted stock grant under the 2023 Restricted Stock Incentive Plan
Verification opinions of the Board of Supervisors of Huakang Co., Ltd. on matters relating to the first grant of the company\'s 2023 restricted stock incentive plan
Announcement of Huakang Co., Ltd. on awarding restricted shares for the first time to incentive recipients of the company\'s 2023 restricted stock incentive plan
Legal opinion from Guohao Lawyers (Hangzhou) Firm on matters relating to the first grant of the 2023 Restricted Stock Incentive Plan of Zhejiang Huakang Pharmaceutical Co., Ltd.
List of first incentive recipients granted in the 2023 Restricted Stock Incentive Plan of Huakang Co., Ltd. (as of the date of initial grant)
Announcement of Huakang Co., Ltd. on matters relating to adjustments to the 2023 Restricted Stock Incentive Plan
Legal opinion from Guohao Lawyers (Hangzhou) Firm on matters relating to the first grant of the 2023 Restricted Stock Incentive Plan of Zhejiang Huakang Pharmaceutical Co., Ltd.
Huakang Co., Ltd.\'s self-inspection report on insider information on the 2023 Restricted Stock Incentive Plan and the stock trading situation of companies whose incentive recipients and incentive recipients are trading
Explanation and verification opinions of the Supervisory Board of Huakang Co., Ltd. on the publication of the list of incentive recipients of the Company\'s 2023 Restricted Stock Incentive Plan
Huakang Co., Ltd.\'s 2023 Restricted Stock Incentive Plan (Draft) Summary Notice
Legal opinion of Mr. Guo Hao (Hangzhou) Firm on Zhejiang Huakang Pharmaceutical Co., Ltd.\'s 2023 Restricted Stock Incentive Plan (Draft)
Analysis
Price Target
No Data
